Maat Pharma SA (MAAT) — Financial Flexibility Index
Maat Pharma SA (MAAT) has a Financial Flexibility Index of -0.37x as of June 2025. Free cash flow of €-15.17 Million (operating CF €-15.37 Million minus capex €202.00K) represents 0% of total liabilities (€40.58 Million). Check asset allocation strategy of Maat Pharma SA to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maat Pharma SA Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Maat Pharma SA across 8 annual periods. See MAAT working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Maat Pharma SA (2017–2024)
Year-by-year free cash flow to debt coverage for Maat Pharma SA. For the full company profile including market capitalisation, see Maat Pharma SA market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.76x | €-21.29 Million | €-22.04 Million | €28.16 Million | ▲ +3.4% |
| 2023 | -0.78x | €-17.58 Million | €-18.67 Million | €22.46 Million | ▼ -17.4% |
| 2022 | -0.67x | €-11.94 Million | €-12.61 Million | €17.91 Million | ▲ +17.1% |
| 2021 | -0.80x | €-7.69 Million | €-7.93 Million | €9.56 Million | ▼ -22.0% |
| 2020 | -0.66x | €-5.50 Million | €-5.81 Million | €8.34 Million | ▼ -71.7% |
| 2019 | -0.38x | €-4.89 Million | €-5.02 Million | €12.73 Million | ▲ +50.5% |
| 2018 | -0.78x | €-3.58 Million | €-3.87 Million | €4.62 Million | ▲ +13.5% |
| 2017 | -0.90x | €-3.58 Million | €-3.87 Million | €3.99 Million | — |